3.A correlated clinical analysis between clinical and cybex results and MRI findings after arthroscopic cruciate ligament reconstruction using patellar bone tendon graft.
Kwang Jin RHEE ; Dae Sik JEON ; Won PARK
The Journal of the Korean Orthopaedic Association 1993;28(6):1988-1995
No abstract available.
Ligaments*
;
Magnetic Resonance Imaging*
;
Tendons*
;
Transplants*
4.A study on cyclic AMP in alveolar bone treated by orthodontic forces.
Dae Sik AHN ; Jong Heun LEE ; Won Sik YANG
Korean Journal of Orthodontics 1981;11(1):7-15
Tooth movement by orthodontic force is based upon alveolar bone resorption at compression site and bone formation at tension site of tooth. The function of cyclic AMP is to participate not only in initial action of bone cells by mechanical forces but also in the continuous cellular response leading, to bone remodeling. This experiment was performed to clarify the role of cyclic AMP in bone remodeling by mechanical forces. The orthodontic forces of about 80 gm and 100 gm were applied to the right canines of maxillary and mandibular bone, respectively, in cats, treated for periods of time ranging from one hour to 28 days. Alveolar bones were obtained from compression and tension sites . surrounding tipping maxillary and mandibular canines as well as from contralateral control sites. The samples were extracted, boiled and homogenized, and the supernatants were assayed for cyclic AMP by a radioimmunoassay mothod. The results were as follows: 1. The orthodontic movement of canines was increased to the end of experimental period and the action of orthodontic forces on tooth movement was more effective in maxillary canine. 2. The cyclic AMP levels of alveolar bones in compression and tension sites initially decreased, then increased and remained elevated to the end of experiment. The differences of the cyclic AMP levels between treated sites and non-treated sites were gradually increased. 3. The cyclic AMP levels in treated sites of mandibular alveolar bone was higher than that of maxillary alveolar bone.
Animals
;
Bone Remodeling
;
Bone Resorption
;
Cats
;
Cyclic AMP*
;
Osteogenesis
;
Radioimmunoassay
;
Tooth
;
Tooth Movement
5.A clinical and electrophysiological studies of vincristine neurotoxicity.
Joong Won KIM ; Jong Ho WON ; Dae Sik HONG ; Hee Sook PARK ; Yang Gyun LEE
Journal of the Korean Cancer Association 1991;23(2):252-258
No abstract available.
Vincristine*
6.Treatment of infected bone loss with ilizarov apparatus in long bones.
Won Sik CHOY ; Kwang Won LEE ; Whan Jeung KIM ; Hyun Dae SHIN ; Ki Seung NAH
The Journal of the Korean Orthopaedic Association 1993;28(7):2581-2588
No abstract available.
7.Relationship between traumatic spinal canal stenosis and neurologic deficits in thoracic and lumbar burst fractures.
Won Sik CHOY ; Whan Jeong KIM ; Kwang Won LEE ; Hyun Dae SHIN ; Yong Su PARK
The Journal of the Korean Orthopaedic Association 1993;28(1):123-129
No abstract available.
Constriction, Pathologic*
;
Neurologic Manifestations*
;
Spinal Canal*
8.MRI of avascular necrosis of femoral head; Correlation with radiograph, radionuclide scan, clinical fidings and histologic examination.
Won Sik CHOY ; Kwang Won LEE ; Whan Jeung KIM ; Hyun Dae SHIN ; Hyun CHU
The Journal of the Korean Orthopaedic Association 1993;28(1):23-31
No abstract available.
Head*
;
Magnetic Resonance Imaging*
;
Necrosis*
9.Acute myelogenous leukemia presenting with pericardial tamponade.
Jee Yun LEE ; Dong Won BYUN ; Jong Ho WON ; Dae Sik HONG ; Hee Sook PARK
Korean Journal of Hematology 1992;27(2):339-343
No abstract available.
Cardiac Tamponade*
;
Leukemia, Myeloid, Acute*
10.The Evaluation of Radiation Therapy and Combined-modality Therapy for Non-small-cell Lung Cancer in Elderly.
Won Sup YOON ; Dae Sik YANG ; Chul Yong KIM
The Journal of the Korean Society for Therapeutic Radiology and Oncology 2007;25(2):101-108
PURPOSE: To compare radiation therapy alone to combined modality therapy about survival rate and tolerance of elderly patients (70=or> or =) with non-small-cell lung cancer (NSCLC). MATERIALS AND METHODS: Between 1998 and 2002, 57 patients given radiation therapy due to NSCLC (Stage III) were analysed retrospectively. Radiation therapy alone (RT), concurrent chemoradiation (CRT), and sequential chemoradiation (SCRT) was done to 33, 16 and 8 patients, respectively. Patients' median age was 74 (range 70~85). Male and female are 51 patients and 6 patients, respectively. 23 patients were stage IIIa and 34 were stage IIIb. Patients' characteristic distribution of RT and CRT was not significantly different except mass size that RT has a bigger than CRT. The fraction size of radiation therapy was 1.8 Gy in CRT and 1.8~3 Gy in other groups. Total radiation dose was 51~63 Gy according to the fraction size. If the prescribed total radiation dose was successfully irradiated, we stated that it was completion of radiation therapy. RESULTS: 52 patients were dead. Median period of radiation therapy was as follow: RT, 35 days, CRT, 60.5 days and SCRT, 35 days. Overall median survival time (MST) was 10.1 months. The 1 yr- and 2 yr-overall survival rate was 39.8% and 17.6%, respectively. MST of RT, CRT and SCRT was 8.9, 8.2 and 11.7 months, respectively. The 1 yr survival rate of RT, CRT and SCRT was 38.4%, 37.5% and 50% (not significant). Patients given incomplete radiation therapy were 12 (RT, 5 CRT, 6 SCRT, 1). N stage (p=0.081) and the difference of treatment methods (p=0.079) were the factors affecting incompletion of radiation therapy, but it was not significant. In case of combined-agents chemotherapy, 4 of 8 ceased radiation therapy. T stage (T> or =3), mass size (> or =5 cm), Karnofsky performance scale (< or =70) and completion of radiation therapy were the prognostic factors in uni- and multi-variate analysis. CONCLUSION: In elderly patients with NSCLC, radiation therapy alone was a treatment method with similar survival period compared with other methods. Generally, patients given radiation therapy alone was tolerable to a treatment. Before planning concurrent chemoirradiation in elderly patients with NSCLC, physicians pay attention to a selection of patients and chemotherapy agents considering general condition and toxicity.
Aged*
;
Combined Modality Therapy
;
Drug Therapy
;
Female
;
Humans
;
Lung Neoplasms*
;
Lung*
;
Male
;
Retrospective Studies
;
Survival Rate